IP Flow
Cutting edge analysis and commentary at the intersection of Intellectual Property Law and Investing.
-
The Markman Note: Activists at Qualcomm’s Gate
Apr 21, 2015(Comments: 2)Apr. 21, 2015 (Mimesis Law) — It was another busy week at the intersection of investing and intellectual property, with continued patent litigation activity of interest to investors — across a number of industry sectors. Welcome... -
Markman Minute: Takeaways From Marvell Oral Arguments
Apr 16, 2015(Comments: 1)Apr. 16, 2015 (Mimesis Law) — Oral arguments were recently heard at the US Court of Appeals in Washington DC in the appeal of a massive $1.5 billion patent infringement verdict against Marvell Semiconductor in the... -
Markman Minute: Rovi Takes On Netflix
Apr 11, 2015(Comments: 2)Apr. 11, 2015 (Mimesis Law) — Gaston breaks down what’s at stake for companies and shareholders in the latest stage of Rovi’s patent infringement fight against Netflix....Read More -
The Markman Note: Rovi on the Ropes?
Apr 2, 2015(Comments: 0)Apr. 2, 2015 (Mimesis Law) — It was a wild week at the intersection of investing and intellectual property, with four big litigation-induced moves in some names that we have been monitoring for a while. Welcome... -
Markman Minute: Marvell’s Billion Dollar Fight
Mar 31, 2015(Comments: 3)Mar. 31, 2015 (Mimesis Law) — After losing the largest patent verdict to date, Marvell Technology Group looks to oral arguments in the appeal the over $1.5 billion decision favoring Carnegie Mellon. Gaston breaks down what... -
The Markman Note: Marvell, Enzo Biochem, Spherix
Mar 23, 2015(Comments: 1)Mar. 24, 2015 (Mimesis Law) — Welcome to the first issue of the Markman Note, a special section on Mimesis Law focusing on the intersection of investing and intellectual property. For the most part we’ll be...
